Feasibility of a Mindfulness-Based Stress Reduction Program for Early-Stage Breast Cancer Survivors

Abstract

Participants enrolled in the MBSR classes generally were compliant. Significant improvement in psychological status, symptoms, and QOL can be achieved with MBSR use in this population.

Investigating efficacy of two brief mind–body intervention programs for managing sleep disturbance in cancer survivors: a pilot randomized controlled trial

“…The mixed effects ANCOVA indicated that the three groups did not differ from one another ( p  = .279). The magnitude of change observed in the MBB group seems comparable to that (4.7 from pre to post) reported in one recent study of MBSR for cancer survivors [70] or those (5.7 from pre to post or 3.8 improvement relative to the wait-list control) reported in another recent study of MBSR for cancer patients [52]. …”

“…The magnitudes of these improvements are larger or comparable to what was reported (4.7 improvement from pre to post) in a recent feasibility study of an MBSR program for early stage breast cancer survivors [70]. Mixed effects ANCOVA of CES-D yielded p  = .078 and  = .088, overall.…”

Audio recordings of mindfulness-based stress reduction training to improve cancer patients’ mood and quality of life—a pilot feasibility study

“…While there have been several published reports of MBSR programs for newly diagnosed cancer patients, these interventions have required patients to attend classes [29][30][31][32], and we are aware of only two published studies in which MBSR was delivered individually to patients outside a didactic framework and simultaneous with treatment. Rosenbaum and colleagues designed an intervention for inpatients receiving hematopoietic stem cell transplant in which participants received individualized meditation instruction along with a CD of meditation instructions.…”

Mindfulness-Based Stress Reduction, Mindfulness-Based Cognitive Therapy, and Zen Meditation for Depression, Anxiety, Pain, and Psychological Distress

“…Furthermore, there is compelling evidence that these circuits exhibit abnormal functioning in mood 151 and at least some anxiety disorders. [152][153][154][155][156] Several studies suggest that MPs increase activation of the basal ganglia 98,100,135,146 and thalamus. 94 It is not currently known whether these changes contribute to the effects of MPs on mood, anxiety, or pain symptoms, possibly through enhanced control of cognitive and emotional processing.…”